What Does Science Say About Maryland Rep. Andy Harris’s Opposition to Natural Psychedelics?
Scientific research does not support his statements that psychedelics are “very potent” and “very dangerous.”
Plants, Substances and Products - Page 7
Get to Know the Beta Carbolines – Newcomers to the Science of Magic Mushrooms
Understanding the pharmacology of magic mushrooms is not just about tryptamines anymore.
The Biosynthesis of DMT
Understanding this is more important than ever in psychedelic research because scientists think DMT may be an endogenous neurotransmitter.
UNC to Receive $26.9M from DARPA to Develop Psychiatric Medicines
The research will use cutting-edge technology to attempt to remove undesirable side-effects from drugs targeting GPCRs, including the serotonin receptors where psychedelics act.
What is Salvia divinorum?
The primary active compound in this plant is more potent than LSD.
MDMA for PTSD Showing Promising Outcomes for Patients in MAPS Phase 3 Trials
“In the pharmaceutical drug development community, this is what you dream about.”
CaaMTech Partners with the National Institutes of Health to Study Synthetic Tryptamines
This collaboration will determine the full scope of the pharmacological effects of several synthetic tryptamine compounds.
Stopping Bad LSD Trips with “Off-Switch” Technology
This technology developed by MindMed and Liechti Lab may help ease some of the concerns surrounding psychedelic therapy.
New Biosynthesis of Psilocybin and Related Tryptamines
Researchers took the psilocybin-making genes from P. cubensis and put them into S. cerevisiae allowing them to produce psilocybin, several of its analogs, and a “new to nature” compound.
Comparing Aeruginascin and Bufotenidine
Although aeruginascin is only present in psilocybin mushrooms and bufotenidine is present in toads, their structural and chemical similarities may be surprising.